SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Takeda Pharmaceutical Co. Ltd. Release: Revestive® (teduglutide) Receives European Marketing Authorization for the Treatment of Adults With Short Bowel Syndrome (SBS)